BLDpharm LOGO®
Keyword Search List Search Structure Search
| EN
Currency :
Choose your country/region & currency
  • Americas
    • Europe
      • Asia Pacific
        • Africa & Middle East
          |
          Cart 0
          Home>Bulk Products>Lithium 2-hydroxy-4,4,5,5-tetramethyl-2-(1-methyl-1H-pyrazol-4-yl)-1,3,2-dioxaborolan-2-uide

          About Us

          Founded in 2014, BLD Pharmatech Ltd. is a leading supplier and manufacturer of research chemicals to pharmaceutical companies, universities, biotech companies,healthcare industries,contract research organizations etc.


          With its own R&D center in Shanghai, BLD Pharmatech Ltd. main field of expertise covers the development and production of heterocycles,boronic acids, amino acids, metal catalysts and chiral compounds.

          Qualifications

          ISO9001 ISO14001 ISO45001 Certified
          DUNS: 560440352

          BD216680[1173889-20-7]Lithium 2-hydroxy-4,4,5,5-tetramethyl-2-(1-methyl-1H-pyrazol-4-yl)-1,3,2-dioxaborolan-2-uide*

          Specific Information

          Purity : 98% Specific Rotation :
          NMR(H/C/F/S/P) : E.E. :
          HPLC : Water Content :
          Polymerization Inhibitor : Single Impurity :
          Melting Point : Density :
          Packaging : Solubility :
          Name Note : Acetic Acid :
          Beilstein : Grade :
          Specific Gravity : Viscosity :
          Others :
          +86-21-61629022 sales@bldpharm.com Inquiry

          Product Details

          Cat No. : BD216680 Synonyms : Lithium 2-hydroxy-4,4,5,5-tetramethyl-2-(1-methyl-1H-pyrazol-4-yl)-1,3,2-dioxaborolan-2-uide
          CAS No. : 1173889-20-7 MDL NO : MFCD16987688
          Formule : C10H18BLiN2O3 InChI Key : N/A
          M.W : 232.01 Pubchem ID :
          Boiling Point :

          Safety

          Signal Word : Class : N/A
          Precautionary Statements : UN# : N/A
          Hazard Statements : Packing Group : N/A
          GHS Pictogram:

          R&D Center